← NOVARTIS AG NVS
Market Price
$150.91
Market Cap
$289.38B
P/E Ratio
21.11
Revenue (FY 2025)
↑9.6% YoY
$56.67B
3-Yr CAGR: 3.0%
Net Income
↓-750.0% YoY
-$17.00M
Net Margin: -0.0%
Free Cash Flow
↓-41.2% YoY
-$1.24B
FCF Yield: -0.43%
EPS (Diluted)
↑21.8% YoY
$7.15
Basic: $7.21
Return on Equity
Efficiency
N/A
ROA: -0.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (NVS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $49,436.0M | — | $31,916.0M | $-14.0M | — | — | — | $43.0M | $-1,819.0M | — |
| FY 2017 | $50,135.0M | +1.4% | $32,960.0M | — | +100.0% | $3.17 | — | $97.0M | $-1,599.0M | +12.1% |
| FY 2018 | $53,166.0M | +6.0% | $34,759.0M | $3.0M | — | $5.46 | +72.2% | $243.0M | $-1,530.0M | +4.3% |
| FY 2019 | $48,677.0M | -8.4% | $34,252.0M | $5.0M | +66.7% | $3.08 | -43.6% | $214.0M | $-1,165.0M | +23.9% |
| FY 2020 | $49,898.0M | +2.5% | $34,777.0M | $-1.0M | -120.0% | $3.52 | +14.3% | $47.0M | $-1,228.0M | -5.4% |
| FY 2021 | $52,877.0M | +6.0% | $37,010.0M | $-3.0M | -200.0% | $10.63 | +202.0% | $13.0M | $-1,365.0M | -11.2% |
| FY 2022 | $51,828.0M | -2.0% | $36,342.0M | — | +100.0% | $2.76 | -74.0% | $254.0M | $-944.0M | +30.8% |
| FY 2023 | $46,660.0M | -10.0% | $34,188.0M | $4.0M | — | $4.10 | +48.6% | $645.0M | $-415.0M | +56.0% |
| FY 2024 | $51,722.0M | +10.8% | $38,895.0M | $-2.0M | -150.0% | $5.87 | +43.2% | $489.0M | $-877.0M | -111.3% |
| FY 2025 | $56,674.0M | +9.6% | $42,975.0M | $-17.0M | -750.0% | $7.15 | +21.8% | $310.0M | $-1,238.0M | -41.2% |
Valuation
Market Price
$150.91
Market Cap
$289.38B
Enterprise Value
N/A
P/E Ratio
21.11
P/B Ratio
N/A
FCF Yield
-0.43%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
75.83%
Operating Margin
31.13%
Net Margin
-0.03%
Return on Equity (ROE)
N/A
Return on Assets (ROA)
-0.02%
Asset Turnover
0.51x
Revenue 3-Yr CAGR
3.02%
Financial Health & Liquidity
Current Ratio
0.10
Cash Ratio
N/A
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
N/A
Total Debt
N/A
Book Value / Share
N/A
Cash Flow Efficiency
Operating Cash Flow
$310.00M
Capital Expenditures (CapEx)
$1.55B
Free Cash Flow
-$1.24B
OCF / Revenue
0.55%
FCF / Revenue
-2.18%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$7.15
EPS (Basic)
$7.21
Dividends / Share
N/A
Book Value / Share
N/A
EPS YoY Growth
21.81%
Balance Sheet (FY 2025)
Total Assets
$110.95B
Total Liabilities
$64.40B
Stockholders' Equity
N/A
Current Assets
$205.00M
Current Liabilities
$1.97B